Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance ...

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of. Mr. Sandoval’s appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved ...

Car enthusiast ThatDudeInBlue reviews the Ford Focus SVT, the granddaddy of Focus ST models.

The month of February is known as American Heart Month, and mothers are often considered the “heartbeat” of the family. I ...

The Reverse Valsalva maneuver utilizes forced inspiration against an occluded airway to generate negative intrathoracic ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

CARDAMYST is now conveniently available to patients through retail pharmacies National sales force hired with promotional launch in mid-February Expected $25 copay cap for eligible commercially ...

CARDAMYST is now conveniently available to patients through retail pharmacies National sales force hired with promotional launch in mid-February Expected $25 copay cap for eligible commercially ...

Credit: Milestone Pharmaceuticals. Each nasal spray device delivers 2 sprays containing a total of etripamil 70mg. The intranasal therapy consists of a novel calcium channel blocker and is designed to ...

Years of high-intensity exercise may come with an unexpected heart risk for male endurance athletes over the age of 50, according to new research from the University of Leeds. The study, published ...